Streetbeat News

Stock Prices

NBY

NovaBay Pharmaceuticals Inc (NASDAQ:NBY) shares surged by 50% to $0.18 despite no new company-specific news. The rise follows last week's launch of new Avenova product bundles for dry eye relief, aligning with the 2024 Eyes on Eyecare Dry Eye Report. CEO Justin Hall highlighted the growing prevalence of dry eye syndrome and the expected market growth from $3.02 billion in 2023 to $4.86 billion by 2030.

Portfolio Pulse from Henry Khederian

May 20, 2024 | 6:59 pm

NFLX

Netflix shares are trading higher following a bullish rating reiteration by Wedbush.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 6:59 pm

INTU

SNOW

WDAY

ZM

JPMorgan analyst Mark Murphy issued ratings for enterprise software companies Zoom, Snowflake, Intuit, and Workday, highlighting short-term volatility but long-term growth potential. Murphy gave Neutral ratings to Zoom and Intuit, and Overweight ratings to Snowflake and Workday.

Portfolio Pulse from Hayden Buckfire

May 20, 2024 | 6:53 pm

MRX

Analysts have initiated coverage on Marex Group (NASDAQ:MRX) with positive ratings and price targets, following its IPO last month. The company reported strong financial results for fiscal 2023, indicating substantial growth.

Portfolio Pulse from Vaishali Prayag

May 20, 2024 | 6:50 pm

LRCX

The article discusses the recent options trading activity for Lam Research (NASDAQ:LRCX), highlighting a bullish sentiment among large investors. The majority of trades were calls, indicating positive expectations for the stock. Analysts have mixed ratings, with price targets ranging from $850 to $1150.

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 6:45 pm

BTBT

BTCT

CLSK

MARA

MSTR

RIOT

WULF

Shares of crypto-related stocks are trading higher amid a rise in Bitcoin.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 6:43 pm

AMGN

AZN

Amgen and AstraZeneca announced results from the Phase 2a COURSE trial of Tezspire for severe COPD, showing mixed efficacy results. The drug showed a 17% reduction in COPD exacerbations overall, but more significant reductions in specific patient subgroups. The safety profile was consistent with its approved severe asthma indication.

Portfolio Pulse from Vandana Singh

May 20, 2024 | 6:38 pm

AMZN

APO

PARA

SONY

Paramount Global's stock has been declining, exacerbated by Warren Buffett's Berkshire Hathaway selling its stake. The stock is trading below key moving averages, indicating bearish sentiment. Despite some short-term bullish indicators, the overall trend remains negative. Paramount has also faced leadership changes and failed merger talks.

Portfolio Pulse from Surbhi Jain

May 20, 2024 | 6:35 pm

PEPEUSD

SPY

The crypto community is excited about Pepe (PEPE) as traders predict it may retest all-time highs this week. Key support/resistance level is $0.00905. PEPE added 530 new holders, totaling 220,672. Whale movements and institutional holdings are significant. PEPE is currently trading at $0.000009518, up 5% in 24 hours.

Portfolio Pulse from Khyathi Dalal

May 20, 2024 | 6:33 pm

KRRO

Korro presented additional preclinical data for KRRO-110 at the American Thoracic Society 2024 International Conference. KRRO-110 demonstrated sustained editing efficiency and significantly increased alpha-1 antitrypsin protein levels in a genetic AATD mouse model.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 6:33 pm